These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3039771)

  • 1. Restriction enzyme analysis of HLA class II DR beta genes in patients with Graves' disease.
    Boehm BO; Schifferdecker E; Kuehnl P; Rosak C; Schöffling K
    Acta Endocrinol Suppl (Copenh); 1987; 281():146-8. PubMed ID: 3039771
    [No Abstract]   [Full Text] [Related]  

  • 2. Linkage of HLA-DR beta specific restriction fragment length polymorphisms with Graves' disease.
    Boehm BO; Schifferdecker E; Kuehnl P; Schöffling K
    Acta Endocrinol (Copenh); 1988 Oct; 119(2):251-6. PubMed ID: 2902722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Southern blot analysis of HLA class II beta genes in relation to HLA-D, DR specificities.
    Otani F; Okuda M; Kashiwagi N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):817-21. PubMed ID: 3824495
    [No Abstract]   [Full Text] [Related]  

  • 4. Localization of HLA-DR alpha-chain messenger ribonucleic acid in normal and autoimmune human thyroid using in situ hybridization.
    Piccinini LA; Goldsmith NK; Schachter BS; Davies TF
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1307-15. PubMed ID: 2453529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA typing of HLA-DR beta chain genes can discriminate between undetected alleles and real homozygotes.
    de Préval C; Angelini G; Boogh B; Ferrara GB; Mach B
    Immunogenetics; 1987; 26(4-5):249-57. PubMed ID: 2820873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of HLA-DR5 detected by serologic, cellular, and molecular techniques.
    Singal DP; Butler L; Reid B; D'Souza M; Lamontagne L
    Transplant Proc; 1987 Feb; 19(1 Pt 1):822-5. PubMed ID: 3493565
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-DP, DQ and DR gene expression in Graves' disease and normal thyroid epithelium.
    Piccinini LA; Goldsmith NK; Roman SH; Davies TF
    Tissue Antigens; 1987 Oct; 30(4):145-54. PubMed ID: 3120348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II genes of the human major histocompatibility complex. Organization and evolutionary relationship of the DR beta genes.
    Andersson G; Larhammar D; Widmark E; Servenius B; Peterson PA; Rask L
    J Biol Chem; 1987 Jun; 262(18):8748-58. PubMed ID: 3036826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an HLA-DR beta pseudogene in the DRw52 supertypic group.
    Rollini P; Mach B; Gorski J
    Immunogenetics; 1987; 25(5):336-42. PubMed ID: 3032786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class II DNA genotypes in Graves' disease: clues to inheritance of the HLA-linked component of susceptibility.
    Fletcher J; Franklyn JA; McLachlan SM; Young E; Sheppard MC
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):539-47. PubMed ID: 2908104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease.
    Philippou G; Krimitzas A; Kaltsas G; Anastasiou E; Souvatzoglou A; Alevizaki M
    J Endocrinol Invest; 2001 Feb; 24(2):88-91. PubMed ID: 11263477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class II associations in juvenile Graves' disease: indication of a strong protective role of the DRB1*0701,DQA1*0201 haplotype.
    Lavard L; Madsen HO; Perrild H; Jacobsen BB; Svejgaard A
    Tissue Antigens; 1997 Dec; 50(6):639-41. PubMed ID: 9458117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus.
    Garcia-Ameijeiras A; Gladman DD; Chan JY; Volpé R
    Clin Invest Med; 1993 Oct; 16(5):326-32. PubMed ID: 7903231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of major histocompatibility complex alleles in the susceptibility of Brazilian patients to develop the myogenic type of Graves' orbitopathy.
    Akaishi PM; Cruz AA; Silva FL; Rodrigues Mde L; Maciel LM; Donadi EA
    Thyroid; 2008 Apr; 18(4):443-7. PubMed ID: 18352820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
    Nagataki S
    Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells.
    Faure GC; Bensoussan-Lejzerowicz D; Bene MC; Aubert V; Leclere J
    Clin Immunol Immunopathol; 1997 Aug; 84(2):212-5. PubMed ID: 9245555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenetics of endocrine ophthalmopathy and Graves' disease.
    Badenhoop K; Schleusener H; Usadel KH
    Dev Ophthalmol; 1993; 25():11-9. PubMed ID: 8359345
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and distribution of three serologically undetected alleles of HLA-DR by oligonucleotide.DNA typing analysis.
    Tiercy JM; Gorski J; Jeannet M; Mach B
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):198-202. PubMed ID: 3422418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of the HLA-DRB3 gene in Graves' disease: predominance of allele Dw24.
    Semana G; Allanic H; Quillivic F; Vallejo MT; Simon JP; Genetet B; Fauchet R
    Hum Immunol; 1990 Oct; 29(2):143-9. PubMed ID: 1979072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.